Leukemia/lymphoma-associated PLCG1 mutations induce both cell-autonomous and bystander T cell activation and drug resistance ...

Bayer extends CEO contract amid 'signs of success' Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan for the group starts to deliver ...